Celiac disease

Celiac Disease, also known as celiac sprue or gluten-sensitive enteropathy, causes damage to the small intestine in response to gluten consumption. Below are COVID news and research updates that specifically relate to Celiac Disease.

Can You Get Celiac Disease From a COVID-19 Infection?

A recent article explores the potential association between COVID-19 infection and the development of celiac disease. The researchers hypothesized that there might be an increased risk of developing celiac disease due to a COVID-19 infection potentially triggering an autoimmune response in genetically predisposed individuals or the COVID-19 infection disrupting the intestinal barrier function, altering the immune response and contributing to the development of celiac disease.

Read More »

Risk of Developing Autoimmune Disease Following COVID-19 Infection

A recent study exploring the association between COVID-19 infection and the risk of developing autoimmune diseases was conducted by a team of researchers from various institutions in Taiwan using data from the “TriNetX database, which holds the largest global COVID-19 dataset.” The team analyzed the medical record data of 3.8 million patients in the U.S., of which 888,460 had received a COVID-19 diagnosis (polymerase chain reaction–confirmed) between January 1, 2020, and December 31, 2021.

Read More »

Autoimmunity & COVID: Are You More at Risk?

Researchers in Italy studied whether autoimmunity increased the risk of SARS-CoV-2 infection in patients not taking immunosuppressive drugs. Researchers contacted 400 patients with the following autoimmune diseases: autoimmune gastritis, celiac disease, autoimmune thyroid disease (both Graves’ disease and Hashimoto’s thyroiditis), and Type 1 diabetes. Positive COVID-19 test results were reported in 33 patients. Only 3 of the 33 patients required hospitalization, while 8 were asymptomatic, and 22 had mild symptoms. No deaths were recorded.

Read More »

Covid-19 Outcomes in Autoimmune Disease Patients

Autoimmune disease is currently considered a risk factor for severe COVID-19. A research article published in Rheumatology last Fall summarized 30-day outcomes of autoimmune disease (AD) patients following hospitalization with COVID-19. AD patients diagnosed and/or hospitalized between January and June 2020 with COVID-19 were included, and their 30 day outcomes were compared to patients with at least one AD hospitalized with influenza from September 2017 through April 2018.

Read More »